Jonathan P Piccini Selected Research

Factor Xa (Coagulation Factor Xa)

1/2022	Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
10/2021	Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial.
1/2021	Clinical Characteristics and Outcomes Associated With Oral Anticoagulant Use Among Patients Hospitalized With Intracerebral Hemorrhage.
1/2018	Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial.
11/2017	Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
8/2017	Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).
6/2017	Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial.
1/2017	Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation Trial).
1/2017	Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) Analysis.
7/2016	On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan P Piccini Research Topics

Disease

210	Atrial Fibrillation 12/2022 - 06/2008
107	Stroke (Strokes) 08/2022 - 06/2008
73	Hemorrhage 08/2022 - 09/2011
63	Heart Failure 02/2022 - 03/2004
53	Embolism (Embolus) 01/2022 - 06/2008
19	Myocardial Infarction 01/2022 - 12/2008
16	Ventricular Tachycardia 01/2021 - 11/2005
12	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 10/2012
11	Ventricular Fibrillation 01/2019 - 11/2005
10	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2021 - 09/2011
10	Cardiac Sudden Death (Sudden Cardiac Arrest) 10/2018 - 11/2005
9	Hypertension (High Blood Pressure) 02/2022 - 09/2009
9	Transient Ischemic Attack 01/2022 - 09/2009
7	Chronic Renal Insufficiency 09/2021 - 08/2011
6	Infections 02/2022 - 11/2014
5	Tachycardia (Tachyarrhythmias) 01/2022 - 02/2011
5	Heart Diseases (Heart Disease) 01/2022 - 02/2015
5	Ischemic Stroke 01/2022 - 09/2011
5	Atrial Flutter (Flutter, Atrial) 12/2021 - 01/2016
5	Shock 01/2020 - 04/2011
5	Acute Coronary Syndrome 09/2016 - 06/2008
4	Cardiomyopathies (Cardiomyopathy) 02/2022 - 08/2008
4	Thrombosis (Thrombus) 01/2022 - 06/2008
4	Vascular Diseases (Vascular Disease) 01/2020 - 01/2018
4	Frailty 01/2019 - 07/2013
4	Chronic Obstructive Pulmonary Disease (COPD) 11/2018 - 03/2014
4	Anemia 12/2015 - 09/2009
3	Bacteremia 02/2022 - 01/2019
3	Fistula 08/2020 - 01/2017
3	Diabetes Mellitus 08/2020 - 07/2013
3	Mitral Valve Stenosis (Mitral Stenosis) 12/2017 - 12/2014
3	Venous Thromboembolism 03/2017 - 06/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2014 - 11/2013
2	Heart Arrest (Cardiac Arrest) 08/2022 - 01/2019
2	Bradycardia 02/2022 - 10/2018
2	Peripheral Arterial Disease 01/2022 - 01/2014
2	Left Ventricular Dysfunction 01/2022 - 03/2011
2	Cerebral Hemorrhage 01/2021 - 10/2015
2	Cardiac Arrhythmias (Arrythmia) 10/2020 - 01/2020
2	Hyperlipidemias (Hyperlipidemia) 01/2020 - 07/2013
2	Chronic Kidney Failure (Chronic Renal Failure) 12/2019 - 08/2015
2	Supraventricular Tachycardia 10/2019 - 03/2015
2	Fibrosis (Cirrhosis) 10/2019 - 04/2017
2	Neoplasms (Cancer) 01/2019 - 01/2017
2	Endocarditis 01/2019 - 06/2013
2	Cognitive Dysfunction 01/2019 - 12/2018
2	Obstructive Sleep Apnea 11/2018 - 05/2015
2	Thromboembolism 01/2018 - 10/2016
2	Carotid Artery Diseases 01/2018 - 01/2018
2	Death (Near-Death Experience) 01/2017 - 06/2015
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 03/2016 - 07/2013

Drug/Important Bio-Agent (IBA)

74	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 09/2009
54	RivaroxabanIBA 01/2022 - 06/2008
48	Vitamin K FDA Link 01/2022 - 05/2012
37	AnticoagulantsIBA 01/2022 - 07/2010
32	Factor Xa (Coagulation Factor Xa)IBA 01/2022 - 01/2013
24	Anti-Arrhythmia AgentsIBA 08/2022 - 07/2010
12	Pharmaceutical PreparationsIBA 01/2019 - 10/2012
11	N(4)-oleylcytosine arabinosideIBA 01/2021 - 01/2016
10	Factor Xa InhibitorsIBA 01/2022 - 07/2010
10	Amiodarone (Amiodarona)FDA LinkGeneric 01/2021 - 05/2009
10	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 04/2012
9	CreatinineIBA 01/2022 - 01/2013
7	apixabanIBA 01/2022 - 07/2010
6	bucindololIBA 02/2022 - 06/2015
6	Dronedarone FDA Link 01/2022 - 09/2009
5	Sotalol (Sotalol Hydrochloride)FDA LinkGeneric 01/2022 - 09/2014
5	Dabigatran FDA Link 11/2018 - 09/2013
4	Metoprolol (Toprol-XL)FDA LinkGeneric 02/2022 - 12/2017
3	N-methylvalineIBA 01/2022 - 01/2020
3	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 08/2008
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2015
3	Adenosine Triphosphate (ATP)IBA 01/2020 - 03/2015
3	Digoxin (Digitek)FDA LinkGeneric 11/2018 - 06/2015
2	dofetilide (Tikosyn)FDA Link 01/2022 - 06/2015
2	Insulin (Novolin)FDA Link 06/2021 - 01/2017
2	IceIBA 01/2020 - 12/2014
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 08/2017 - 09/2015
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 09/2016 - 01/2016

Therapy/Procedure

99	Therapeutics 08/2022 - 11/2005
56	Catheter Ablation 12/2022 - 12/2009
18	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 10/2018 - 11/2005
8	Cardiac Resynchronization Therapy 02/2022 - 04/2007
8	Electric Countershock (Cardioversion) 12/2021 - 05/2013
7	Drug Therapy (Chemotherapy) 08/2022 - 09/2012
7	Percutaneous Coronary Intervention 12/2021 - 09/2008
6	Defibrillators (Defibrillator) 02/2022 - 06/2013
6	Contraindications 01/2021 - 04/2014
4	Catheters 08/2020 - 01/2017
4	Device Removal (Removal, Device) 01/2019 - 11/2014
4	Secondary Prevention 03/2015 - 11/2005
3	Length of Stay 12/2022 - 01/2019
3	Patient Readmission 02/2022 - 04/2012
3	Drug Tapering 02/2022 - 01/2018
3	Radiofrequency Ablation 01/2021 - 09/2013
3	Heart-Assist Devices 07/2020 - 11/2014
3	Transcatheter Aortic Valve Replacement 12/2019 - 11/2012
2	Cryosurgery 08/2020 - 12/2011
2	Critical Care (Surgical Intensive Care) 04/2017 - 06/2013
2	Polypharmacy 07/2016 - 01/2016